lutetium lu 177 vipivotide tetraxetan,177lu-psma-617,cabazitaxel
emcure,sanofi,novartis,novartis
['biomarker', ' vision', 'therap ']
suvmean &gt; 10 on psma pet in the vision trial had improved os and pfs. it's extraordinary that we found the same cut-off in our ph2 study and #therap study. **we have a new biomarker** #asco22 
Working together to improve patient outcomes with personalised medicine: PET/CT, theranostics. Nuclear Medicine Physician ?? Prof ????